On 2026-09-02, Scribe Therapeutics Inc. (SCTX) announced earnings per share of $-3.84 for the fiscal quarter ending 2026-06-30, beating the average analyst estimate of $-6.20.

The next expected annoucement date for quarterly earnings is 2026-12-02, with an average estimated earnings per share of $-1.02 for the fiscal quarter ending 2026-09-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.